Home>>PLP (139-151) (trifluoroacetate salt)

PLP (139-151) (trifluoroacetate salt) (Synonyms: linPLP, Proteolipid Peptide (139-151))

Catalog No.GC48331

Products are for research use only. Not for human use. We do not sell to patients.

PLP (139-151) (trifluoroacetate salt) Chemical Structure

Size Price Stock Qty
1mg
$43.00
In stock
5mg
$181.00
In stock
10mg
$321.00
In stock
25mg
$643.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

PLP (139-151) is an encephalitogenic peptide fragment of myelin proteolipid protein (PLP).1 In vivo, PLP (139-151) (150 µg/animal) induces the formation of inflammatory foci, axonal injury, and demyelination in the spinal cord, as well as motor deficits in mice. It is commonly used to induce experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis (MS), in mice.1,2,3

1.Lourbopoulos, A., Matsoukas, M.-T., Katsara, M., et al.Cyclization of PLP139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitisBioorg. Med. Chem.26(9)2221-2228(2018) 2.Reddy, J., Bettelli, E., Nicholson, L., et al.Detection of autoreactive myelin proteolipid protein 139-151-specific T cells by using MHC II (IAs) tetramersJ. Immunol.170(2)870-877(2003) 3.Mohindru, M., Kang, B., and Kim, B.S.Functional maturation of proteolipid protein139-151-specific Th1 cells in the central nervous system in experimental autoimmune encephalomyelitisJ. Neuroimmunol.155(1-2)127-135(2004)

Reviews

Review for PLP (139-151) (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 20 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PLP (139-151) (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.